Last update 01 Nov 2024

ZEN-3694

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
Mechanism
BET inhibitors(Bromodomain and extra terminal domain protein inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic castration-resistant prostate cancerPhase 2
US
26 Jan 2021
Metastatic castration-resistant prostate cancerPhase 2
US
26 Jan 2021
Metastatic Prostate CarcinomaPhase 2
US
26 Jan 2021
Metastatic Prostate CarcinomaPhase 2
US
26 Jan 2021
Small cell carcinoma of prostatePhase 2
US
26 Jan 2021
Small cell carcinoma of prostatePhase 2
US
26 Jan 2021
Triple Negative Breast CancerPhase 2
CN
26 Jun 2019
Triple Negative Breast CancerPreclinical
US
26 Jun 2019
Triple Negative Breast CancerPreclinical
BE
26 Jun 2019
Triple Negative Breast CancerPreclinical
ES
26 Jun 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
22
(eyjldkyxvs) = ZEN 72 mg daily + ENZ 160 mg/day + P 200 mg IV q 3 weeks ddrguazcsg (zmbzahgdcw )
Positive
10 Sep 2022
Phase 1/2
Triple Negative Breast Cancer
ER Negative | PR Negative | HER2 Negative
51
(vjecpuljiv) = RP2D was determined to be 48mg qd ZEN-3694 plus 0.75mg qd talazoparib. vclncnatho (wsxwyengti )
Positive
02 Jun 2022
(TNBC at diagnosis patients)
Phase 1/2
75
(ljmoiuccvi) = uvwzfwmhqm hhkmbgrwmc (amackryfth )
Positive
15 Oct 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free